How Much Does Provigil (Modafinil) Cost in Rhode Island in 2026?

Brand vs. Generic Modafinil Pricing in Rhode Island

The single biggest factor in what you pay is whether you fill brand-name Provigil or a generic equivalent. Cephalon's brand Provigil carries a wholesale acquisition cost near $850 for a 30-day supply of 200 mg tablets, a price point that has remained stable since patent expiration failed to pull the brand price down 1. Generic modafinil, by contrast, averages about $80 per month at Rhode Island retail pharmacies in 2026.

That tenfold gap reflects a pattern the FDA's Office of Generic Drugs has documented repeatedly: brand manufacturers maintain list prices even after generic entry because a small share of prescriptions continue to specify "dispense as written" 2. Rhode Island follows standard generic substitution law, meaning pharmacists may automatically dispense the generic unless the prescriber or patient requests otherwise. If your prescription reads "modafinil 200 mg," expect the generic price at checkout.

Pricing varies by pharmacy. Large chains such as CVS and Walgreens in Providence, Warwick, and Cranston tend to cluster near that $80 average, while independent pharmacies may price slightly higher or lower. The FDA approved modafinil in December 1998 for narcolepsy based on the US Modafinil in Narcolepsy Multicenter Study Group trial, which demonstrated that 200 mg and 400 mg doses significantly reduced daytime sleepiness versus placebo across 283 patients 3. That efficacy profile remains the foundation of clinical use nearly three decades later.

Rhode Island Medicaid Coverage for Modafinil

Rhode Island Medicaid does cover modafinil, but a prior authorization (PA) requirement applies. The PA process exists because Medicaid preferred drug lists (PDLs) classify modafinil as a non-preferred agent that requires documented clinical need before the state will reimburse 4.

To satisfy the PA, prescribers typically must document one of three FDA-approved diagnoses: narcolepsy, residual excessive sleepiness in obstructive sleep apnea despite CPAP therapy, or shift work disorder 1. Off-label cognitive enhancement requests almost always get denied. The American Academy of Sleep Medicine (AASM) practice parameters reinforce that modafinil carries its strongest recommendation (Standard level) for narcolepsy-related excessive daytime sleepiness 5.

Dr. Charles Czeisler of Harvard Medical School has noted that "modafinil offers a distinct pharmacological mechanism from traditional amphetamine-based stimulants, with lower abuse liability reflected in its Schedule IV classification" 6. That lower abuse profile partly explains why Medicaid programs, including Rhode Island's, are willing to cover the drug with appropriate documentation.

Processing time for Rhode Island Medicaid PAs typically runs 24 to 72 hours for standard requests. Urgent or expedited reviews can return within 24 hours when the prescriber attests to clinical urgency. If the PA is denied, enrollees have appeal rights under federal Medicaid regulations 4.

Insurance Coverage Beyond Medicaid

Commercial insurance plans operating in Rhode Island, including Blue Cross Blue Shield of Rhode Island, UnitedHealthcare, Aetna, and Cigna, generally cover generic modafinil on their formularies. Most place it on Tier 2 (preferred generic) or Tier 3 (non-preferred generic), meaning copays typically fall between $10 and $45 per month depending on the specific plan 7.

Brand-name Provigil sits on Tier 4 or the specialty tier for most commercial plans, which can mean copays of $100 to $250 or coinsurance of 25% to 50%. The practical advice is straightforward: request generic modafinil unless you have a documented clinical reason for the brand.

Medicare Part D plans in Rhode Island follow a similar tiering structure. The Centers for Medicare & Medicaid Services (CMS) requires Part D plans to cover at least two drugs per therapeutic class 7. Modafinil and armodafinil (Nuvigil) represent the two primary wake-promoting agents in the class, so coverage for at least one is essentially guaranteed.

Step therapy requirements appear on some plans. A 2005 randomized trial comparing modafinil with placebo in shift work disorder (N=209) showed that modafinil 200 mg significantly improved Clinical Global Impression of Change scores and reduced lapses of attention on the Psychomotor Vigilance Task 8. Plans that impose step therapy for shift work disorder may require documentation that sleep hygiene measures were tried first, consistent with AASM guidelines 5.

Compounded Modafinil in Rhode Island: Legality and Access

Compounded modafinil is available in Rhode Island through 503A-licensed compounding pharmacies. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications based on individual patient prescriptions 9. Rhode Island's Board of Pharmacy recognizes this framework.

The cost advantage can be significant. Some 503A pharmacies in the state offer compounded modafinil formulations at prices well below the generic retail average, particularly for patients paying out of pocket. However, compounded products do not undergo the same FDA bioequivalence testing that approved generics must pass 2. The FDA has repeatedly emphasized this distinction.

Compounding pharmacies can also prepare modafinil in alternative dosage forms, such as sublingual tablets or liquid suspensions, which may benefit patients who have difficulty swallowing standard tablets. A valid prescription from a licensed prescriber is required, and the prescription must be patient-specific under 503A rules 9.

One caution: modafinil remains a Schedule IV controlled substance under federal law 10. Compounding pharmacies must hold appropriate DEA registration and comply with all controlled substance record-keeping requirements. Verify any pharmacy's credentials through the Rhode Island Board of Pharmacy before filling.

Telehealth Prescribing of Modafinil in Rhode Island

Rhode Island permits telehealth prescribing of modafinil. The state's telehealth parity law requires commercial insurers to cover telehealth-delivered services at the same reimbursement rate as in-person visits, a provision that survived post-pandemic legislative review 11.

Because modafinil is Schedule IV, it can be prescribed via telehealth under the DEA's current telehealth prescribing framework. The DEA extended its COVID-era telehealth flexibilities for controlled substances, which allow Schedule III through V prescriptions after an audio-video evaluation 10. Providers must be licensed in Rhode Island or hold a compact license recognized by the state.

Telehealth visits for modafinil typically cost $50 to $150 out of pocket without insurance. Several national telehealth platforms serve Rhode Island residents and can electronically prescribe modafinil to local pharmacies. The Epworth Sleepiness Scale, a validated eight-item questionnaire, is frequently used during telehealth evaluations to quantify excessive daytime sleepiness; a score above 10 generally indicates a clinical problem warranting further evaluation 12.

Savings Strategies for Rhode Island Patients

Multiple pathways exist to lower your modafinil cost in Rhode Island. Here is a practical breakdown.

Pharmacy discount tools. GoodRx, RxSaver, and similar platforms aggregate discount pricing from pharmacy benefit managers. These tools regularly show generic modafinil below $30 for 30 tablets at select Rhode Island pharmacies. The discounts are not insurance and can be used by anyone regardless of coverage status.

Manufacturer savings cards. Some generic manufacturers offer copay assistance programs, though these are less common for modafinil than for newer brand-name drugs. Check manufacturer websites directly.

Pill splitting. Modafinil 200 mg tablets are scored. Some prescribers write for 200 mg tablets with instructions to split, effectively halving the per-dose cost for patients on 100 mg. This approach is supported by the dose-response data from the original narcolepsy trial, which found that 200 mg and 400 mg produced similar reductions in excessive sleepiness on the Maintenance of Wakefulness Test, suggesting 200 mg is the clinically optimal dose for most patients 3.

Patient assistance programs. NeedyMeds and the Partnership for Prescription Assistance maintain databases of programs that may help uninsured or underinsured Rhode Island residents access modafinil at reduced cost 13.

90-day fills. Many commercial plans and pharmacy benefit managers offer lower per-unit pricing for 90-day supplies filled through mail-order pharmacies. A Cochrane review of adherence interventions found that longer prescription durations correlated with improved medication adherence 14, an added benefit beyond cost savings.

Safety Profile and Monitoring Considerations

Modafinil is generally well tolerated. The most common adverse effects in clinical trials were headache (34% vs. 23% placebo), nausea (11% vs. 3%), and nervousness (7% vs. 3%) 1. Serious dermatologic reactions, including Stevens-Johnson syndrome, have been reported rarely; the FDA label includes a warning about this risk 1.

Modafinil induces CYP3A4, which can reduce the efficacy of hormonal contraceptives. The FDA label explicitly warns that women using oral contraceptives should employ an alternative or additional method of contraception during modafinil therapy and for one month after discontinuation 1. This interaction is particularly relevant for telehealth prescribers who may not review the full medication list as thoroughly as in-person encounters.

Cardiovascular monitoring is recommended for patients with pre-existing conditions. A systematic review published in the Annals of Internal Medicine found that modafinil did not significantly increase cardiovascular event rates in clinical trial populations, though the authors noted that trials excluded patients with unstable cardiac disease 15.

Rhode Island prescribers should also be aware that modafinil is detectable on some expanded urine drug panels, though it does not cross-react with standard amphetamine immunoassays 16. Patients in safety-sensitive occupations, common in Rhode Island's maritime and defense sectors, should inform their occupational health providers.

Modafinil vs. Armodafinil: Cost Comparison in Rhode Island

Armodafinil (Nuvigil), the R-enantiomer of modafinil, is the primary therapeutic alternative. Generic armodafinil prices in Rhode Island run approximately $75 to $100 per month, comparable to modafinil. A head-to-head pharmacokinetic study demonstrated that armodafinil 150 mg produces higher plasma concentrations later in the day compared with modafinil 200 mg, which may benefit patients whose sleepiness peaks in the afternoon 17.

From a cost perspective, neither drug holds a consistent advantage in Rhode Island. The choice between them should be clinical, not financial. Both are Schedule IV, both are available as generics, and both carry similar PA requirements under Rhode Island Medicaid.

The dose for modafinil in narcolepsy is 200 mg once daily in the morning. Shift work disorder uses the same 200 mg dose taken one hour before the start of the work shift 1. Patients switching from modafinil to armodafinil typically convert 200 mg modafinil to 150 mg armodafinil based on the pharmacokinetic equivalence data 17.